Arjo AB (publ) (OTCMKTS:ARRJF – Get Free Report) was the recipient of a large drop in short interest during the month of December. As of December 15th, there was short interest totaling 178 shares, a drop of 97.4% from the November 30th total of 6,940 shares. Based on an average daily trading volume, of 200 shares, the short-interest ratio is currently 0.9 days. Based on an average daily trading volume, of 200 shares, the short-interest ratio is currently 0.9 days.
Arjo AB (publ) Stock Performance
Shares of ARRJF stock opened at $3.35 on Thursday. The firm’s 50-day simple moving average is $3.28 and its 200-day simple moving average is $3.17. Arjo AB has a 1-year low of $3.27 and a 1-year high of $3.51.
Arjo AB (publ) Company Profile
Arjo AB (publ) is a Sweden-based medical technology company that develops and markets solutions to enhance patient mobility, hygiene, and well-being in healthcare environments. The company’s product portfolio spans patient handling equipment—such as ceiling lifts, floor-based lifts and support surfaces—designed to reduce the risk of injury to both patients and caregivers. In addition, Arjo offers advanced hygiene systems, therapeutic beds and surfaces, and electronic documentation tools aimed at improving care quality and operational efficiency in hospitals and long-term care facilities.
In the area of prevention, Arjo provides a range of vascular therapy products for reducing the risk of deep vein thrombosis (DVT) and venous thromboembolism (VTE).
Featured Stories
- Five stocks we like better than Arjo AB (publ)
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough
Receive News & Ratings for Arjo AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arjo AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
